"10.1371_journal.pone.0051395","plos one","2012-12-20T00:00:00Z","Vincenzo Libri; Andrew P Brown; Giulio Gambarota; Jonathan Haddad; Gregory S Shields; Helen Dawes; David J Pinato; Ethan Hoffman; Peter J Elliot; George P Vlasuk; Eric Jacobson; Martin R Wilkins; Paul M Matthews","The National Institute for Health Research (NIHR)â€“Wellcome Trust Imperial College Clinical Research Facility, Imperial Centre for Translational and Experimental Medicine, Imperial College London, United Kingdom; Imanova Centre for Imaging Sciences, London, United Kingdom; GSK Clinical Imaging Centre, GlaxoSmithKline, Imperial College, London, United Kingdom; Sirtris Pharmaceuticals, A GSK Company, Cambridge, Massachusetts, United States of America; Movement Sciences Group, Oxford Brookes University, Oxford, United Kingdom; Division of Brain Sciences, Department of Medicine, Imperial College, London, United Kingdom","Conceived and designed the experiments: PMM PJE. Performed the experiments: VL APB GG GSS HD. Analyzed the data: JH EH. Contributed reagents/materials/analysis tools: PJE EJ. Wrote the paper: VL EJ MRW DJP GPV.","At the time this publication was written, JH, EH, PEGPV and EJ were employed by Sirtris Pharmaceuticals, a GlaxoSmithKline company developing SR2104 and related molecules. APB, GG, and PMM were employed by GlaxoSmithKline Research and Development (GSK R&D), Ltd. VL was employed by GSK R&D until April 2009. APB is currently employed by Imanova, Centre of Imaging Sciences, London, UK. The other authors declared no conflicts of interest. The above competing interests do not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2012","12","Vincenzo Libri","VL",13,TRUE,2,5,2,5,TRUE,FALSE,FALSE,0,NA,FALSE
